| Name | Title | Contact Details |
|---|
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.
Adnexus Therapeutics, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Waltham, MA. To find more information about Adnexus Therapeutics, Inc., please visit www.adnexustx.com
Health2047 Inc. is a Silicon Valley integrated innovation enterprise whose mission is to develop, guide, and commercialize disruptive ideas that enhance — at the system level— the practice of healthcare.
Sunrise Manor Nursing Home is a Bay Shore, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.